MMBG Investment Advisors’s AbbVie ABBV Stock Holding History

MMBG Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.72M	Sell	17,115 -27	-0.2%	-$5.99K	0.34%	48
2025 Q4	$3.92M	Buy	17,142 +27	+0.2%	+$6.15K	0.33%	52
2025 Q3	$3.96M	Buy	17,115 +8,055	+89%	+$1.64M	0.35%	47
2025 Q2	$1.68M	Sell	9,060 -2,100	-19%	-$390K	0.17%	70
2025 Q1	$2.34M	Hold	11,160	–	–	0.26%	55
2024 Q4	$1.98M	Hold	11,160	–	–	0.21%	63
2024 Q3	$2.2M	Hold	11,160	–	–	0.23%	62
2024 Q2	$1.91M	Buy	11,160 +615	+6%	+$102K	0.21%	63
2024 Q1	$1.92M	Hold	10,545	–	–	0.2%	67
2023 Q4	$1.63M	Hold	10,545	–	–	0.19%	71
2023 Q3	$1.57M	Hold	10,545	–	–	0.2%	70
2023 Q2	$1.4M	Hold	10,545	–	–	0.17%	74
2023 Q1	$1.68M	Hold	10,545	–	–	0.21%	68
2022 Q4	$1.7M	Hold	10,545	–	–	0.23%	67
2022 Q3	$1.42M	Hold	10,545	–	–	0.19%	72
2022 Q2	$1.61M	Hold	10,545	–	–	0.2%	68
2022 Q1	$1.71M	Hold	10,545	–	–	0.18%	71
2021 Q4	$1.43M	Buy	+10,545	New	+$1.25M	0.14%	78

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MMBG Investment Advisors's ABBV Position: Q1 2026 in Review

MMBG Investment Advisors reduced its AbbVie (ABBV) stake by 0.16% in Q1 2026, selling an estimated $5.99K and leaving 17,115 shares worth $3.72M. The position accounts for 0.34% of the portfolio, ranked #48.

MMBG Investment Advisors first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.96M in Q3 2025. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

MMBG Investment Advisors held 17,115 shares of AbbVie worth $3.72M as of Q1 2026.
MMBG Investment Advisors sold 27 AbbVie shares in Q1 2026, an estimated $5.99K.
AbbVie made up 0.34% of MMBG Investment Advisors's portfolio in Q1 2026, its #48 holding.
MMBG Investment Advisors first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
MMBG Investment Advisors's AbbVie position peaked at $3.96M in Q3 2025.
4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MMBG Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.